H-D-Leu-OH structure
|
Common Name | H-D-Leu-OH | ||
---|---|---|---|---|
CAS Number | 328-38-1 | Molecular Weight | 131.173 | |
Density | 1.0±0.1 g/cm3 | Boiling Point | 225.8±23.0 °C at 760 mmHg | |
Molecular Formula | C6H13NO2 | Melting Point | > 300ºC | |
MSDS | Chinese USA | Flash Point | 90.3±22.6 °C |
Use of H-D-Leu-OHD-Leucine is a more potent anti-seizure agent than L-leucine. D-leucine potently terminates seizures even after the onset of seizure activity. D-leucine, but not L-leucine, reduces long-term potentiation but had no effect on basal synaptic transmission in vitro[1]. |
Name | D-leucine |
---|---|
Synonym | More Synonyms |
Description | D-Leucine is a more potent anti-seizure agent than L-leucine. D-leucine potently terminates seizures even after the onset of seizure activity. D-leucine, but not L-leucine, reduces long-term potentiation but had no effect on basal synaptic transmission in vitro[1]. |
---|---|
Related Catalog | |
Target |
Human Endogenous Metabolite |
In Vitro | In a screen of candidate neuronal receptors, D-leucine failed to compete for binding by cognate ligands, potentially suggesting a novel target. Even at low doses, D-leucine suppressed ongoing seizures at least as effectively as diazepam but without sedative effects. These studies raise the possibility that D-leucine may represent a new class of anti-seizure agents, and that D-leucine may have a previously unknown function in eukaryotes[1]. |
References |
Density | 1.0±0.1 g/cm3 |
---|---|
Boiling Point | 225.8±23.0 °C at 760 mmHg |
Melting Point | > 300ºC |
Molecular Formula | C6H13NO2 |
Molecular Weight | 131.173 |
Flash Point | 90.3±22.6 °C |
Exact Mass | 131.094635 |
PSA | 63.32000 |
LogP | 0.73 |
Vapour Pressure | 0.0±0.9 mmHg at 25°C |
Index of Refraction | 1.463 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
Hazard Codes | Xi |
Risk Phrases | R36/37/38 |
Safety Phrases | 22-24/25-36-26 |
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
RTECS | OH2840000 |
HS Code | 2922499990 |
Precursor 6 | |
---|---|
DownStream 10 | |
HS Code | 2922499990 |
---|---|
Summary | HS:2922499990 other amino-acids, other than those containing more than one kind of oxygen function, and their esters; salts thereof VAT:17.0% Tax rebate rate:9.0% Supervision conditions:AB(certificate of inspection for goods inward,certificate of inspection for goods outward) MFN tariff:6.5% General tariff:30.0% |
Defining transcribed regions using RNA-seq.
Nat. Protoc. 5 , 255-66, (2010) Next-generation sequencing technologies are revolutionizing genomics research. It is now possible to generate gigabase pairs of DNA sequence within a week without time-consuming cloning or massive inf... |
|
Dietary leucine--an environmental modifier of insulin resistance acting on multiple levels of metabolism.
PLoS ONE 6(6) , e21187, (2011) Environmental factors, such as the macronutrient composition of the diet, can have a profound impact on risk of diabetes and metabolic syndrome. In the present study we demonstrate how a single, simpl... |
|
Potent anti-seizure effects of D-leucine.
Neurobiol. Dis. 82 , 46-53, (2015) There are no effective treatments for millions of patients with intractable epilepsy. High-fat ketogenic diets may provide significant clinical benefit but are challenging to implement. Low carbohydra... |
leucine |
D-Leucine |
MFCD00063088 |
(R)-2-Amino-4-methylpentanoic acid |
(2R)-2-amino-4-methylpentanoic acid |
ent-1 |
H-Leu-OH |
D-Homo-valine |
D-2-Amino-4-methylvaleric acid |
H-D-Leu-OH |
(R)-2-Amino-4-methyl-pentanoic acid |
Leucine, D- |
EINECS 206-327-7 |
D-2-Amino-4-methylpentanoicacid |